US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.34

+0.68772.04%

Post-market: 33.65-0.6880-2.00%16:04 EDT

Volume:2K

Turnover:54.52K

Market Cap:13.74M

PE:- -

High:34.34

Open:33.65

Low:33.65

Close:33.65

52wk High:34.98

52wk Low:27.25

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.76

T/O Rate:0.40%

Dividend:0.08

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Biogen - 33.7% of Crossover Participants Report Clear or Almost Clear Skin at Week 52

THOMSON REUTERS

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112

THOMSON REUTERS

Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~

THOMSON REUTERS

J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112

THOMSON REUTERS

J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals

THOMSON REUTERS

Major Drugmakers Turn to China for Licensing Deals

Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen

More Upside Awaits for Gilead Sciences Stock. Stay Invested.

PRECISE and AWS to build systems for Singapore's 450,000-person genomics study

Nurdianah Md Nur

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Biogen Inc. Stock Outperforms Competitors Despite Losses on the Day

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Edwards Lifesciences Receives FDA Approval for Autus Valve, the First Surgical Pulmonary Valve for Pediatric Patients

THOMSON REUTERS

US FDA - Approves Autus Size-Adjustable Valve for Pediatric Congenital Pulmonary Valve Disease

THOMSON REUTERS

US FDA - Edwards Lifesciences Receives FDA Approval for Autus Size-Adjustable Valve

THOMSON REUTERS

Merck's Tulisokibart Data From Hidradenitis Suppurativa Trial Looks Solid, UBS Securities Says

MT Newswires Live

Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing

Gilead Sciences Announces Dividend of R$ 0.2394442440 Per Unit for Brgildbdr 000

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BMED/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":34.338,"timestamp":1791576000000,"preClose":33.6503,"halted":0,"volume":1618,"hourTrading":{"tag":"盘后","latestPrice":33.65,"preClose":34.338,"latestTime":"16:04 EDT","volume":2,"amount":68.676,"timestamp":1791576245424,"change":-0.688,"changeRate":-0.020036,"amplitude":0},"delay":0,"changeRate":0.02043666772658786,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Market Closed","change":0.6877,"latestTime":"10-09 16:00:00 EDT","open":33.65,"high":34.338,"low":33.65,"amount":54516,"amplitude":0.020446,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":33.6503,"sharesOutstanding":360000,"nav":33.670887,"aum":13468354.8,"dividendRate":0.002362,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.65,"preClose":34.338,"latestTime":"16:04 EDT","volume":2,"amount":68.676,"timestamp":1791576245424,"change":-0.688,"changeRate":-0.020036,"amplitude":0},"volumeRatio":0.7584848484166623,"impliedVol":0.2953,"impliedVolPercentile":0.7729},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7584848484166623,"shares":400000,"dividePrice":0.0811,"high":34.338,"amplitude":0.020446,"preClose":33.6503,"low":33.65,"week52Low":27.25,"pbRate":"--","week52High":34.98,"institutionHeld":0,"latestPrice":34.338,"eps":0,"divideRate":0.002362,"volume":1618,"delay":0,"ttmEps":0,"open":33.65,"prevYearClose":30.32,"prevWeekClose":33.7958,"prevMonthClose":34.561,"prevQuarterClose":34.561,"fiveDayClose":33.7958,"twentyDayClose":32.965,"sixtyDayClose":30.5074},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672574863","title":"Biogen - 33.7% of Crossover Participants Report Clear or Almost Clear Skin at Week 52","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574863","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574863?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:20","pubTimestamp":1790954408,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A5:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","PBE","BIIB","LU0109394709.USD","IE00B19Z9Z06.USD","LU0320765992.SGD","BK4532","LU0889565916.HKD","BK4139","BK4533","IE00B19Z9P08.USD","BMED","LU0234570918.USD","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672716311","title":"Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716311","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716311?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:05","pubTimestamp":1790935529,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced new two-year data from the Phase 3 ICONIC-TOTAL study demonstrating the positive impact of ICOTYDE on high-impact plaqu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE000M9KFDE8.USD","BK4534","LU2471134952.CNY","SG9999013999.USD","LU1496350502.SGD","SGXZ57979304.SGD","BK4592","LU2896262040.SGD","LU1732800096.USD","IE0002270589.USD","JDOC","IXJ","MEDX","JNJ","LU1043141396.HKD","RXL","IE00BDGV0183.EUR","BMED","LU0162691827.USD","LU0426412945.USD","IE00BJT1NW94.SGD","LU0738911758.USD","LU2505996509.AUD","IYH","LU1066053197.SGD","SG9999002224.SGD","LU2417539215.USD","TRUH","BK4588","IE00B19Z3B42.SGD","LU2468319806.SGD","XLV","IE000WAW04H5.SGD","LU0466842654.USD","LU2430703251.USD","LU1551013425.SGD","PJP","LU0640476718.USD","IE00B2B36J28.USD","IHE","FTXH","FHLC","VHT","LU0234570918.USD","LU0203345920.USD","BK4581","LU0994945656.USD","LU1551013342.USD","LU2236285917.USD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715109","title":"Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715109","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715109?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:01","pubTimestamp":1790935267,"startTime":"0","endTime":"0","summary":"Johnson & Johnson says ICOTYDE sustains psoriasis skin clearance through 2 years in Phase 3 ICONIC-TOTAL studyJohnson & Johnson disclosed new two-year Phase 3 ICONIC-TOTAL results for ICOTYDE (icotrok","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8bWfkV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BBT3K403.USD","MEDX","LU2129689605.HKD","FTXH","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","TRUH","IHE","VHT","LU1043141123.HKD","BK4592","LU1061106388.HKD","LU1430594728.SGD","GDOC","LU0162691827.USD","FHLC","LU1732800096.USD","LU1043141396.HKD","LU1629891620.HKD","JNJ","IE00B4R5TH58.HKD","BMED","LU2430703251.USD","SG9999001176.USD","LU2417539215.USD","XLV","IXJ","JDOC","LU0820561818.USD","IYH","LU0234572021.USD","PJP","LU0994945656.USD","LU1066051225.USD","LU2456880835.USD","LU2347655156.SGD","SG9999002224.SGD","LU1066051811.HKD","LU0545039389.USD","LU1674673691.USD","SG9999001440.SGD","LU0426412945.USD","LU2896262040.SGD","IE00BLSP4452.SGD","LU0072461881.USD","LU0738911758.USD","IE0000B7K699.USD","RXL","IE0034235303.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672971590","title":"J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672971590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672971590?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0162691827.USD","LU1674673691.USD","LU0320765646.SGD","LU1221951046.USD","JDOC","LU1061106388.HKD","LU2347655156.SGD","LU2471134879.HKD","LU1551013342.USD","IXJ","LU0820561909.HKD","LU1989771016.USD","IHE","LU1066051498.USD","BK4581","LU0426417589.USD","LU2129689605.HKD","LU2592432038.USD","LU0820562030.AUD","LU1551013425.SGD","VHT","LU1935042991.SGD","XLV","FHLC","LU0234572021.USD","BK4568","LU1162221912.USD","SGXZ80539844.SGD","LU0912757837.SGD","LU0057025933.USD","MEDX","IE00B19Z3581.USD","PJP","BMED","FTXH","IE00BFTCPJ56.SGD","LU0072461881.USD","IYH","IE00B4R5TH58.HKD","LU0795875169.SGD","LU0882574055.USD","GDOC","TRUH","IE00BLSP4452.SGD","LU1121112475.USD","RXL","LU0426412945.USD","JNJ","IE0001KFT4U8.USD","LU1496350502.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672900715","title":"Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~","url":"https://stock-news.laohu8.com/highlight/detail?id=2672900715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672900715?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JNJ","LU0203347892.USD","LU0432979614.USD","LU0820562030.AUD","IYH","XLV","LU0122379950.USD","LU1674673691.USD","IE00BVYPNV92.GBP","LU0472753341.HKD","LU1551013342.USD","LU1267930813.SGD","IHE","LU0511384066.AUD","IE00BKVL7J92.USD","RXL","TRUH","IE00BDGV0183.EUR","FTXH","IXJ","LU0820561909.HKD","IE00BGHQF631.EUR","LU2750360641.GBP","IE00BVYPNW00.USD","LU0795875086.SGD","IE00BSNM7G36.USD","BK4581","LU0882574055.USD","PJP","IE0009355771.USD","BMED","MEDX","LU0234570918.USD","LU1066051225.USD","LU1989771016.USD","BK4550","LU0203345920.USD","LU1228905037.USD","VHT","LU0889566641.SGD","LU1430594728.SGD","JDOC","LU1066053197.SGD","LU1003077747.HKD","GDOC","LU0792757196.USD","BK4568","LU0070217475.USD","LU1221951129.SGD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715972","title":"J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715972?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","LU0072461881.USD","JDOC","LU1732800096.USD","LU2129689514.USD","LU1074936037.SGD","IE000BZT7R73.USD","LU0345770993.USD","XLV","LU2456880835.USD","LU0964807845.USD","IE000F7OJYX1.SGD","BK4588","IE000MB6IJN5.SGD","LU1043141123.HKD","IE00B1BXHZ80.USD","MEDX","LU1145028129.USD","SG9999002232.USD","LU2505996681.GBP","RXL","VHT","IXJ","LU1983299246.USD","PJP","IE00BFTCPJ56.SGD","LU1221951129.SGD","LU1267930813.SGD","GDOC","LU0210528500.USD","LU1506573853.SGD","BMED","LU0162691827.USD","FHLC","TRUH","IYH","LU0203347892.USD","IE00B19Z3B42.SGD","LU0820562030.AUD","BK4581","LU2471134879.HKD","FTXH","LU1551013425.SGD","LU0545562505.USD","IHE","JNJ","LU1914381329.SGD","LU0345769128.USD","IE00BN8TJ469.HKD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672171597","title":"J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672171597","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672171597?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066053197.SGD","MEDX","LU0792757196.USD","IE00BVYPNV92.GBP","BMED","LU1674673691.USD","LU2750360641.GBP","IHE","IE00BGHQF631.EUR","LU0122379950.USD","LU0472753341.HKD","LU0820561909.HKD","GDOC","IE00BDGV0183.EUR","IE00BSNM7G36.USD","LU0203347892.USD","LU0432979614.USD","LU0820562030.AUD","LU1228905037.USD","LU0882574055.USD","LU1551013342.USD","LU0203345920.USD","IYH","IE00BVYPNW00.USD","FTXH","LU1430594728.SGD","FHLC","BK4568","LU1989771016.USD","BK4550","PJP","JDOC","IE0009355771.USD","JNJ","XLV","LU0795875086.SGD","LU1221951129.SGD","TRUH","LU1003077747.HKD","RXL","LU0234570918.USD","VHT","LU0511384066.AUD","IXJ","IE00BKVL7J92.USD","LU0889566641.SGD","LU0070217475.USD","BK4581","LU1267930813.SGD","LU1066051225.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU1481599808.USD","LU0122379950.USD","LU0234570918.USD","LU1551013425.SGD","LU1066051498.USD","02096","BK0196","LU0354030511.USD","03933","LU0053666078.USD","LU2213496289.HKD","LU2357627491.SGD","LU0149534421.HKD","LU0203201768.USD","LU0234572021.USD","BK4559","LU1267930227.SGD","BK4585","LU1989772923.USD","LU1655091616.SGD","SG9999018865.SGD","LU2324357040.USD","LU2114397693.USD","LU1116320901.HKD","SG9999003800.SGD","LU0708995401.HKD","LU1923622614.USD","IE00B1XK9C88.USD","LU0109981661.USD","LU1868836757.USD","LU1146622755.USD","PPH","SG9999004220.SGD","LU0496365809.HKD","LU0965509010.AUD","LU1261432733.SGD","LU2491050071.SGD","LU1894683348.USD","LU1078025761.USD","LU0795875086.SGD","LU2399975544.HKD","LU0882574055.USD","LU1226287792.SGD","BK4566","LU2495084118.USD","LU0976567544.SGD","LU0889566641.SGD","LU1309081286.SGD","LU2580892862.HKD","LU1267930573.SGD","LU1781817850.SGD","LU1291159041.SGD","LU0315179316.USD","LU0575583348.USD","LU0109394709.USD","PFE","LU1064927863.SGD","IE00BBT3K403.USD","LU1670628061.USD","TRUH","LU0634319403.HKD","LU0882574139.USD","LU1019634622.SGD","LU1202635105.USD","LU0133085943.USD","LU1934455194.USD","LU1170363599.USD","LU1941712264.USD","LU0960981461.USD","KURE","IE00BKDWB100.SGD","LU1003076772.USD","LU2039709279.SGD","LU0477156953.USD","IE000WAW04H5.SGD","LU0348827113.USD","LU0130102774.USD","LU0310800379.SGD","IE00BDGV0183.EUR","LU2097828805.USD","IE00BFTCPJ56.SGD","LU0823434740.USD","LU2125909593.SGD","LU1969619763.USD","LU1127390331.HKD","LU1064130708.USD","LU2089984988.USD","LU0868494617.USD","LU2129689431.USD","09995","LU0963555726.SGD","LU1496350171.SGD","SG9999001440.SGD","LU1066051811.HKD","LU2750360997.AUD","LU0502904849.HKD","GLAM","IE00B4JS1V06.HKD","LU2552382132.HKD","LU2347655156.SGD","LU0553294199.USD","LU0106261372.USD","LU1400636657.SGD","LU1712237335.SGD","LU2539964713.USD","LU0395794307.EUR","LU1548497426.USD","LU0823399737.USD","ILDR","LU0079474960.USD","LU2362540622.SGD","LU2491049909.HKD","LU0969580561.USD","LU2023251221.USD","LU2111349929.HKD","THNR","BK4532","IE00BN29S564.USD","LU1226287529.USD","IE0002270589.USD","LU0889565080.SGD","LU1064131342.USD","LU2063271972.USD","LU2646069778.SGD","BK1589","LU2293690082.USD","IE00B3T34201.USD","LU2108987350.USD","IE00BFXG1179.USD","IXJ","IE000SO60NU8.SGD","LU0203347892.USD","BK0012","SMMT","01276","LU0326950275.SGD","LU0971552830.HKD","LU2896262040.SGD","BK4548","LU1098665638.USD","LU2125154778.USD","LU1093756325.SGD","LU1228905037.USD","LU0128525929.USD","CURE","LU1037948541.HKD","LU0784383803.USD","LU0114720955.EUR","MRK","LU0672654240.SGD","LU0949170772.SGD","LU0868494708.USD","LU1236620834.HKD","LU2279689827.SGD","LU2289578879.USD","LU2168563687.JPY","01530","IE00BN8TJ469.HKD","LU1496350502.SGD","IE000M9KFDE8.USD","LU0130517989.USD","LU1328277881.USD","IE00BLSP4239.USD","LU0171276677.USD","IE00BJJMRZ35.SGD","LU1046248800.SGD","LU0256863811.USD","IE0008368742.USD","LU0708994859.HKD","LU2129689514.USD","LU0323591593.USD","LU2242646821.SGD","LU0689472784.USD","LU0965509101.SGD","BK4535","LU0077335932.USD","LU1019632923.USD","LU0561508036.HKD","LU2293690249.USD","BK1191","LU0098860793.USD","LU1580142542.USD","LU1997244956.HKD","IBBQ","LU2264538146.SGD","LU2242644610.SGD","LU0210536198.USD","LU0289739699.SGD","LU0109391861.USD","LU0949170426.SGD","SGXZ99366536.SGD","LU1831875114.USD","LU0057025933.USD","MEDX","LU0306807586.USD","LU1323610961.USD","LU1941712348.USD","LU0985320562.USD","LU1015430645.USD","LU0096364046.USD","LU1629891620.HKD","LU0557290698.USD","LU0820561818.USD","LU2125909247.SGD","LU0545562505.USD","IE00BWXC8680.SGD","LU2265009873.SGD","LU0320765992.SGD","LU1255011170.USD","IE00B031HY20.USD","LU2476274308.USD","LU0417516571.SGD","LU0889565916.HKD","LU2462591350.SGD","LU2347655073.USD","SG9999015986.USD","LU2462157665.USD","LU0061475181.USD","LU0971552673.USD","MHIP","LU0072461881.USD","IE00B3PB1722.GBP","HRTS","LU1732800096.USD","LU0140636845.USD","BMED","LU2237443549.SGD","LU2328871848.SGD","XLV","LU2491050154.USD","LU2468319806.SGD","600276","LU0471298777.SGD","LU0211331839.USD","LU0390134368.USD","LU0348784397.USD","LU0463099449.HKD","LU0348766576.USD","LU0965509283.SGD","SG9999014898.SGD","LU2237443895.HKD","LU1153584641.USD","LU0316494557.USD","LU0354030438.USD","LU1035773651.USD","LU1074936037.SGD","IE000F7OJYX1.SGD","NVO","03165","BNTX","LU2133065610.SGD","WDNA","LU0972486137.USD","LU0011850046.USD","LU2242652126.USD","LU0640476718.USD","GDOC","LU2237443382.USD","SG9999014914.USD","LU0640478417.SGD","LU1979441026.SGD","LLYX","LU1003077747.HKD","IBB","LU2361044949.HKD","LU0320765646.SGD","IE0034235071.USD","LU2168564222.USD","BK0060","LLYZ","LU2596442595.SGD","LU2129689605.HKD","LU0124676726.USD","IE00BVYPNV92.GBP","LU2097828557.USD","LU1720051017.SGD","LU0211327993.USD","LU2471134879.HKD","IE00BGHQF631.EUR","IE00BPRC5H50.USD","BK1161","LU0310800965.SGD","IE00BFSS7M15.SGD","LU2236285917.USD","BK0183","LU1226288170.HKD","LU1273509221.SGD","LU0289961442.SGD","IE0008369823.USD","LU0211328371.USD","LU0067412154.USD","LU0417517546.SGD","SG9999014575.USD","IE00BSNM7G36.USD","LU1400636574.HKD","LU0511384066.AUD","LU2471134796.USD","BK4588","IE0004445239.USD","GSK.UK","BK4550","IE000MB6IJN5.SGD","IE00B775H168.HKD","LU0244354667.USD","LU0980610538.SGD","LU0265550946.USD","LU2087625088.SGD","LU1720050803.USD","LU2360106947.USD","IE00BZ1G4Q59.USD","BK0239","LU1813983027.USD","LU0417516902.SGD","LU1623119135.USD","LU0266013472.USD","LU0047473722.SGD","LU0499090636.EUR","LU1894683264.USD","LU0029864427.USD","LU1201861249.SGD","IE0004445015.USD","IE00BZ08YS42.EUR","SG9999011175.SGD","LU0265550359.USD","BK4592","SG9999018857.SGD","LU2237443465.HKD","LU2168564065.EUR","IE0001KFT4U8.USD","LU1032466523.USD","LU1188198961.HKD","LU0820561909.HKD","LU0455707207.USD","LLII","LU1064131003.USD","LU1670711040.USD","LU2097828474.EUR","LU1226288253.USD","LU2028103732.USD","LU2580892789.USD","LU0310799852.SGD","LU1670710661.SGD","LU2211815571.USD","LU0289739343.SGD","LU0786609619.USD","SG9999017495.SGD","LU1880407132.USD","LU0964807845.USD","SG9999001176.USD","IE00BJJMRX11.SGD","LU1152091754.HKD","LU1196032939.SGD","LU0943347566.SGD","IE00BWDBJ516.SGD","LU0321505439.SGD","LU0920783379.SGD","IE0000B7K699.USD","LU0957799991.USD","LU0965508806.USD","LU1116320737.USD","LU1119994496.HKD","LU0912757837.SGD","IE00BJLML261.HKD","LU2087621335.USD","LU1718418525.SGD","LU1934455277.USD","SG9999014880.SGD","LU2433249047.HKD","LU2168564495.EUR","LU1302929846.USD","LU2746668974.SGD","TMED","LU0726765562.USD","LU1162221912.USD","LU1093756168.USD","LU0069063385.USD","LU0320765489.SGD","IYH","LU1035775433.USD","LU1267930813.SGD","LU1691799644.USD","LU0784384876.USD","LU1400636491.USD","LU1732799900.SGD","LU1280957306.USD","LU0070302665.USD","MEDI","LU0540923850.HKD","LU1355424745.HKD","LU0203345920.USD","LU1997245177.USD","BK4534","LU2237443622.USD","LU1863844665.USD","SGXZ57979304.SGD","LU0094547139.USD","LU0985481810.HKD","LU0861579265.USD","IE00B19Z3B42.SGD","LU1983299246.USD","LU1084165304.USD","LU0405327148.USD","SG9999001176.SGD","LU0225284248.USD","LU1699723380.USD","LU1934455863.HKD","SGXZ51526630.SGD","TBXU","SG9999002232.USD","IE000BZT7R73.USD","LU1366192091.USD","LU0942090050.USD","LU1807302812.USD","ABBV","AZN.UK","01093","LU0417516738.SGD","LU0857590862.USD","LU1551013342.USD","LU0345770308.USD","LU1244550494.USD","LU2750360641.GBP","LU2361045086.USD","IE0005OL40V9.USD","LU1585245621.USD","LU1839511570.USD","LU0256863902.USD","LU0320765059.SGD","LU1066051225.USD","SG9999014542.SGD","LU0306806265.USD","LU2362541513.USD","IE00BKPKM429.USD","IE00B42XCP33.USD","LU2023250330.USD","LU2168564149.EUR","LU0237698245.USD","LU0456855351.SGD","LU0545039389.USD","LU0880133367.SGD","LU0738911758.USD","LU1328615791.USD","LU0162691827.USD","LU1829250122.USD","IE0002141913.USD","LLY","LU2357305700.SGD","LU2471134952.CNY","SG9999015358.SGD","LU2461242641.AUD","RHHBY","LU2756315318.SGD","LU0058720904.USD","LU0345777659.USD","LU1244550221.USD","ELIL","LU0859254822.USD","NVOC","LU0827474353.SGD","LU1046234339.USD","LU1023059063.AUD","BK1521","LU1989772840.SGD","LU0661504455.SGD","SGXZ81514606.USD","SG9999015341.SGD","BK1587","LU0683600562.USD","LU0170899867.USD","LU2091194634.USD","LU0823416689.USD","LU1670756490.USD","IE00B1BXHZ80.USD","LU0128525689.USD","LU1868837300.USD","SG9999014906.USD","LU0607220059.USD","LU0072913022.USD","LU0006306889.USD","NVOH","IE00BQJZX424.USD","LU0795875169.SGD","LU1035777561.USD","IE00B3M56506.USD","IE00BK4W5L77.USD","LU2271345857.HKD","LU2456880835.USD","LU3187612489.SGD","SG9999014567.USD","LU0225771236.USD","LU1804176565.USD","LU0198837287.USD","IE00B5MMRT66.SGD","SGXZ31699556.SGD","LU1868836914.USD","LU1232071149.USD","LU1037948897.HKD","LU1670627923.USD","LU1267930730.SGD","LU1993786604.SGD","LU0174119429.USD","LU0648001328.SGD","LU2097828714.EUR","LU1720051108.HKD","LU2097828631.EUR","LU1153585028.USD","NVS","LU2476274720.SGD","BK4599","BBH","IHE","LU0689626769.HKD","IE00B7KXQ091.USD","SG9999015945.SGD","LU0526926950.USD","SG9999013999.USD","LU2417539215.USD","LU0353189763.USD","LU1883839398.USD","BK1574","LU1226287875.USD","LU0472753341.HKD","IE00BFSS8Q28.SGD","LU0787776722.HKD","00013","LU2148510915.USD","IE0034235188.USD","LU1571399168.USD","LU1961090484.USD","LU2023250843.SGD","BK1583","HK0000165453.HKD","LU0405327494.USD","LU0471298694.HKD","LU0432979614.USD","BMY","LU1868836591.USD","688331","JDOC","RXL","NVOX","LU1051770623.HKD","LU1061106388.HKD","LU1670710588.SGD","IE00BKPKM643.USD","IE00B4R5TH58.HKD","LU0997586515.USD","LU1244550577.SGD","LU0321505868.SGD","LU1974910355.USD","01801","IE00BVYPNW00.USD","LU0203202063.USD","IE00BJT1NW94.SGD","IE00BJJMRY28.SGD","BK0188","BK4581","BK4516","LU2361044865.SGD","688506","BK0028","LU0345777147.USD","LU1951186391.HKD","LU2089283258.USD","LU0466842654.USD","PJP","LU1152091168.USD","LU2106854487.HKD","LU2471134523.USD","IE00BK4W5M84.HKD","09926","LU0171293334.USD","LU2488822045.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU1066053197.SGD","LU1989771016.USD","SG9999015978.USD","LU2552382215.SGD","LU1880407215.USD","LU1481600234.SGD","LU0047473722.EUR","PAWZ","LU2746668461.USD","BK1515","IE00B2B36J28.USD","LU0987226296.USD","LU1057294990.SGD","LU0348783233.USD","LU0385154629.USD","LU1069347547.HKD","LU0348825331.USD","LU2756315664.SGD","LU1487256676.USD","BK4007","LU0501845795.SGD","LU0784385840.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","IE00BLSP4452.SGD","LU0097036916.USD","BK1588","FTXH","LU0225283273.USD","LU1814569148.SGD","LU2552382058.USD","LU0820562030.AUD","LU2237443978.SGD","SG9999015952.SGD","BK4578","LU0161305163.EUR","LU0211326839.USD","LU2112291526.USD","LU0920840948.USD","SG9999014559.SGD","CANC","HCM","LU0964806797.USD","LU0887340254.USD","LU2237438978.USD","IE00BKVL7J92.USD","LU1104425308.USD","LU0052756011.USD","LU1794554557.SGD","LU2125154935.USD","LU1988902786.USD","IE00B19Z3581.USD","LU0345770993.USD","LU1645745479.HKD","LU1820825898.SGD","VHT","LU0267386448.USD","LU0208291251.USD","BK4139","LU1929549753.HKD","LU1670711123.USD","IE0009355771.USD","LU0158827948.USD","GB00BDT5M118.USD","LU0348767384.USD","LU2362541273.HKD","LU0158827781.USD","LU1960683339.HKD","OZEM","LU1430594728.SGD","LU0784385170.HKD","LU0348735423.USD","BK4533","LU0353189680.USD","LU1868837136.USD","LU2778985437.USD","LU0823434583.USD","FHLC","LU0997586432.USD","LU1301847155.USD","03692","ELIS","LU1863844749.USD","LU0757432116.USD","LU1917777945.USD","AGNG","BK1593","BK5011","LU2089284900.SGD","LU1236620750.USD","LU1145028129.USD","LU2355687059.USD","LU1267930490.SGD","SG9999002224.SGD","LU0792757196.USD","LU2602419157.SGD","LU1228905540.USD","LU1069344957.HKD","BK4551","BK4568","LU0238689110.USD","LU1008478684.HKD","REGN","LU0154236417.USD","LU0211326755.USD","LU1997245094.SGD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672790916","title":"Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2672790916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672790916?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:57","pubTimestamp":1790927874,"startTime":"0","endTime":"0","summary":"UPDATE 3-Novartis strikes up to $7.8 billion mRNA deal with China's AbogenOct 2 (Reuters)-Chinese biotech company Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Nov","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","FTXH","RXL","LU0203347892.USD","LU0942090050.USD","SG9999015358.SGD","LU0098860793.USD","LU1291159041.SGD","LU1261432733.SGD","LU2106854487.HKD","LU0920783379.SGD","FHLC","SGXZ57979304.SGD","LU1430594728.SGD","MRNY","GDOC","LU0162691827.USD","LU0976567544.SGD","MRNA","MRNX","AZN.UK","BMED","BK4007","LU0757432116.USD","PAWZ","MRK","IXJ","03165","LU0823416689.USD","LU0171293334.USD","WDNA","LU2112291526.USD","IE00BKPKM643.USD","IE00BLSP4239.USD","JDOC","XLV","IHE","LU1989771016.USD","IDNA","LU1880407132.USD","LU0070302665.USD","TRUH","HRTS","VHT","LU0011850046.USD","LU1814569148.SGD","GNOM","LU1051770623.HKD","LGHT","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672796376","title":"More Upside Awaits for Gilead Sciences Stock. Stay Invested.","url":"https://stock-news.laohu8.com/highlight/detail?id=2672796376","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672796376?lang=en_us&edition=fundamental","pubTime":"2026-10-02 10:25","pubTimestamp":1790907900,"startTime":"0","endTime":"0","summary":"Healing the world can lead to healthy gains too.Shares of Gilead Sciences are up some 35% since Barron's highlighted them a year ago, citing the company's strong and growing portfolio of HIV and oncol","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1066053197.SGD","BK4578","IE00BZ1G4Q59.USD","LU1778281490.HKD","LU1934455194.USD","LU2468319806.SGD","IBB","IE00BSNM7G36.USD","LU1037948541.HKD","LU0882574055.USD","GILD","IE00BKVL7J92.USD","LU0889565916.HKD","LU2089984988.USD","LU1430594728.SGD","TBXU","IE00B19Z3581.USD","BK4585","LU0965509283.SGD","SG9999015986.USD","LU1934455277.USD","IBBQ","LU0859254822.USD","LU1023059063.AUD","LU0114720955.EUR","BMED","SG9999015978.USD","TMED","LU1585245621.USD","LU2357627491.SGD","LU0965509010.AUD","BK4550","LU0965508806.USD","IE00B19Z3B42.SGD","LU0823416689.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BBH","SG9999015945.SGD","LU1057294990.SGD","LU1839511570.USD","LU1066051498.USD","LU1674673691.USD","BK4139","BIB","MEDI","IE0002270589.USD","LU0965509101.SGD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672124741","title":"PRECISE and AWS to build systems for Singapore's 450,000-person genomics study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672124741","media":"Nurdianah Md Nur","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672124741?lang=en_us&edition=fundamental","pubTime":"2026-10-02 08:45","pubTimestamp":1790901919,"startTime":"0","endTime":"0","summary":"Working with implementation partner Temus, PRECISE and AWS will develop systems to store and analyse genetic data while keeping it in Singapore.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/digitaledge/healthcare/precise-and-aws-build-systems-singapores-450000-person-genomics-study?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/digitaledge/healthcare/precise-and-aws-build-systems-singapores-450000-person-genomics-study?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["FWD","PBE","DARP","IDNA","GNOM","BMED","GNMX","TARK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672916767","title":"Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672916767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672916767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:28","pubTimestamp":1790890080,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slid 5.01% to $14.02 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's fourth consecutive day of losses.Perrigo Co. PLC closed 38.10% below its 52-week high of $22.65, which the company reached on October 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Procter & Gamble Co.  fell 0.92% to $143.95, and Abbott Laboratories  fell 2.17% to $96.69.Trading volume  remained 247,637 below its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UGE","LU1043141396.HKD","SG9999002232.USD","IHI","SG9999015341.SGD","LU1551013425.SGD","XLV","BMED","LU1221951129.SGD","RXL","JNJ","SGXZ80539844.SGD","MEDX","LU1162221912.USD","LU1506573853.SGD","PJP","LU0289961442.SGD","IE00B3PB1722.GBP","GDOC","FTXH","IE00B19Z3581.USD","LU0069063385.USD","LU1721429402.USD","IE000WAW04H5.SGD","FHLC","LU2112291526.USD","LU0289739343.SGD","XLP","PG","IE000F7OJYX1.SGD","SGXZ23171101.USD","JDOC","BK4534","TMED","FSTA","LU1718418525.SGD","VHT","LU2552382132.HKD","IE00BLSP4452.SGD","LU0994945656.USD","IHE","LU1721429741.USD","TRUO","TRUH","IXJ","LU0289739699.SGD","IYH","PRGO","LU0345769631.USD","ABT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762246","title":"Biogen Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762246","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762246?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:54","pubTimestamp":1790888040,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  shed 1.35% to $222.82 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's third consecutive day of losses.Biogen Inc. closed 3.33% short of its 52-week high of $230.49, which the company reached on September 28th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Pfizer Inc.  fell 1.40% to $28.12, and AbbVie Inc.  fell 0.63% to $259.93.Trading volume  eclipsed its 50-day average volume of 936,474.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B19Z9Z06.USD","BIIB","BMED","BK4585","IE00B894F039.SGD","LU0320765992.SGD","BK4588","LU0109394709.USD","IE00B19Z9P08.USD","BK4532","LU0234570918.USD","PBE","BK4533","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762679","title":"Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762679?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:33","pubTimestamp":1790886780,"startTime":"0","endTime":"0","summary":"DJ Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  slipped 1.03% to $143.81 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's second consecutive day of losses.Merck & Co. Inc. closed 8.35% short of its 52-week high of $156.92, which the company reached on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Pfizer Inc.  fell 1.40% to $28.12, and Eli Lilly & Co.  fell 0.62% to $1,149.85.Trading volume  remained 2.2 million below its 50-day average volume of 10.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU1057294990.SGD","SG9999002232.USD","MRK","LU1291159041.SGD","BK4559","BMED","SG9999001440.SGD","LU1983299246.USD","LU0208291251.USD","IE00BLSP4239.USD","LU0861579265.USD","LU2361044865.SGD","LU1430594728.SGD","LU2324357040.USD","LU0238689110.USD","LU1989771016.USD","LU1066051811.HKD","LU0965508806.USD","LU0203345920.USD","LU1061106388.HKD","LU0265550359.USD","LU1923622614.USD","BK4534","LU0266013472.USD","LU0985320562.USD","LU0320765646.SGD","LU1571399168.USD","LU2461242641.AUD","LU0980610538.SGD","LU1066053197.SGD","LU0234572021.USD","LU1037948897.HKD","LU2125909247.SGD","LU0689626769.HKD","LU0942090050.USD","LU0823416689.USD","LU2023250504.SGD","LU1929549753.HKD","LU1093756168.USD","LU2106854487.HKD","LU0472753341.HKD","LU0868494708.USD","LU0965509010.AUD","LU0057025933.USD","PAWZ","LU1066051498.USD","BK4516","LU0006306889.USD","FTXH","IE00BFTCPJ56.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0070302665.USD","LU0289739343.SGD","LU1585245621.USD","LU2089984988.USD","JDOC","SG9999002224.SGD","LU1989772840.SGD","LU1941712264.USD","LU2361045086.USD","IE00BSNM7G36.USD","LU2023250843.SGD","LU1974910355.USD","LU0965509101.SGD","LU0130102774.USD","IE00BN8TJ469.HKD","SG9999015358.SGD","SG9999014542.SGD","LU1934455863.HKD","LU0211331839.USD","LU0289739699.SGD","LU2125154935.USD","IYH","LU1093756325.SGD","LU1116320737.USD","LU2125909593.SGD","LU0432979614.USD","HRTS","SG9999014575.USD","LU1201861249.SGD","XLV","LU1989772923.USD","RXL","LU0868494617.USD","LU0162691827.USD","LU1917777945.USD","LU0072461881.USD","SG9999013999.USD","LU0069063385.USD","LU2491049909.HKD","IE00B1BXHZ80.USD","SG9999001176.SGD","LU0058720904.USD","LU0265550946.USD","LU1934455277.USD","IE00BBT3K403.USD","LU2468319806.SGD","LU1941712348.USD","TRUH","LU0477156953.USD","IE0009355771.USD","BK4550","IXJ","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0124676726.USD","SG9999014559.SGD","SG9999014567.USD","SGXZ57979304.SGD","SG9999015341.SGD","LU1069347547.HKD","LU1934455194.USD","BK4588","LU0965509283.SGD","LU1066051225.USD","LU1162221912.USD","LU0289961442.SGD","LU2360032135.SGD","LU1037948541.HKD","SG9999001176.USD","GDOC","LU1699723380.USD","FHLC","LU0859254822.USD","LU1032466523.USD","LU0203347892.USD","LU2357627491.SGD","BK4007","BK4533","LU0122379950.USD","LU2491050071.SGD","LU0130517989.USD","LU1116320901.HKD","LU1023059063.AUD","LU2361044949.HKD","LU2125154778.USD","LU0320765489.SGD","VHT","LU0648001328.SGD","IE00BLSP4452.SGD","IHE","LU2491050154.USD","PPH","LU2433249047.HKD","BK4585","LU0511384066.AUD","LU1035773651.USD","IE000M9KFDE8.USD","IE00BJJMRZ35.SGD","LU0098860793.USD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672815762","title":"Edwards Lifesciences Receives FDA Approval for Autus Valve, the First Surgical Pulmonary Valve for Pediatric Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2672815762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672815762?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:26","pubTimestamp":1790886360,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA1JQQHH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001176.USD","SG9999001176.SGD","BK4585","AGNG","IHI","IE00BFXG0V08.USD","LU0345774631.USD","SG9999013999.USD","IE00BN0W2T93.GBP","LU0345774391.USD","IE00BN0W2W23.USD","LU0058720904.USD","BMED","IE00BN0W2V16.EUR","EW","IE00BYQQ9H92.USD","SGXZ57979304.SGD","BK4588","BK4504","LU0823416689.USD","BK4567","BK4082","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672176114","title":"US FDA - Approves Autus Size-Adjustable Valve for Pediatric Congenital Pulmonary Valve Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2672176114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672176114?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:11","pubTimestamp":1790881866,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N1KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001176.USD","BK4567","LU0345774391.USD","IE00BN0W2V16.EUR","IE00BYQQ9H92.USD","BK4585","LU0345774631.USD","AGNG","IHI","IE00BN0W2T93.GBP","LU0823416689.USD","IE00BFXG0V08.USD","IE00BN0W2W23.USD","SGXZ57979304.SGD","BK4504","BK4588","BMED","BK4082","LU0289739699.SGD","SG9999013999.USD","SG9999001176.SGD","LU0058720904.USD","EW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672149761","title":"US FDA - Edwards Lifesciences Receives FDA Approval for Autus Size-Adjustable Valve","url":"https://stock-news.laohu8.com/highlight/detail?id=2672149761","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672149761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:11","pubTimestamp":1790881866,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N1KW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0289739699.SGD","SG9999013999.USD","IE00BN0W2T93.GBP","SG9999001176.SGD","LU0823416689.USD","LU0345774391.USD","BK4588","AGNG","SGXZ57979304.SGD","LU0345774631.USD","IE00BYQQ9H92.USD","BMED","EW","BK4082","LU0058720904.USD","BK4567","SG9999001176.USD","IE00BFXG0V08.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4504","IHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672766900","title":"Merck's Tulisokibart Data From Hidradenitis Suppurativa Trial Looks Solid, UBS Securities Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672766900","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672766900?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:38","pubTimestamp":1790872694,"startTime":"0","endTime":"0","summary":"Merck's  data from a phase 2b study evaluating tulisokibart in hidradenitis suppurativa looks solid, potentially adding another indication for tulisokibart as management plans to advance into a phase 3 trial, UBS Securities said in a note Wednesday.The company reported a 29% to 37% placebo adjusted hidradenitis suppurativa clinical response 50 between the four-week dose and two-week dose at week 16, which appeared to be in-line or better than the phase 2 data from UCB's Bimzelx, the investment firm said.Even if phase 3 efficacy comes down slightly, UBS said tulisokibart could still be a meaningfully differentiated product as a novel mechanism compared with current standard of care.As tulisokibart can be dosed either at a two-week interval or a four-week interval, the investigational drug could be priced slightly higher with potentially more frequent dosing for the hidradenitis suppurativa indication, the firm said.UBS Securities has a buy rating on the stock, with a $175 price target.M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0006306889.USD","LU1162221912.USD","LU1066051811.HKD","LU2361044865.SGD","LU1430594728.SGD","BMED","LU0265550359.USD","LU2125154778.USD","IXJ","XLV","LU0106261372.USD","LU0122379950.USD","LU2491049909.HKD","LU2461242641.AUD","LU2106854487.HKD","IE00B1BXHZ80.USD","LU1066051498.USD","LU1093756168.USD","RXL","LU0289739343.SGD","LU1116320901.HKD","LU0234572021.USD","LU0203345920.USD","LU0868494708.USD","LU1037948541.HKD","SG9999001176.SGD","LU0868494617.USD","LU0477156953.USD","LU0980610538.SGD","LU2468319806.SGD","LU1941712348.USD","SG9999014542.SGD","LU0859254822.USD","LU2125154935.USD","BK4550","LU0823416689.USD","IE00B4R5TH58.HKD","SG9999001176.USD","LU0985320562.USD","IE00B2B36J28.USD","LU0965509010.AUD","LU0861579265.USD","LU0320765646.SGD","FHLC","IE00BJT1NW94.SGD","LU0124676726.USD","IE00BN8TJ469.HKD","LU2023250843.SGD","LU2491050154.USD","LU1934455194.USD","BK4585","BK4559","BK4588","LU1934455277.USD","LU0069063385.USD","LU0098860793.USD","SGXZ57979304.SGD","LU1941712264.USD","LU1983299246.USD","GDOC","PAWZ","SG9999002232.USD","IHE","IE0009355771.USD","LU1989772840.SGD","IE00BJJMRZ35.SGD","IE000M9KFDE8.USD","LU1066051225.USD","SG9999014575.USD","LU0648001328.SGD","LU1093756325.SGD","LU0432979614.USD","LU0070302665.USD","LU0511384066.AUD","LU2125909593.SGD","LU1057294990.SGD","LU0265550946.USD","FTXH","LU0208291251.USD","LU1917777945.USD","SG9999014567.USD","LU1201861249.SGD","LU0689626769.HKD","LU2360032135.SGD","SG9999014559.SGD","LU0203347892.USD","LU1061106388.HKD","LU2089984988.USD","LU0942090050.USD","LU1974910355.USD","HRTS","LU0965508806.USD","LU0238689110.USD","LU1035773651.USD","LU1923622614.USD","MRK","LU0320765489.SGD","BK4534","IE0002141913.USD","LU2125909247.SGD","IE00BSNM7G36.USD","LU2023250504.SGD","IE00BLSP4239.USD","LU0472753341.HKD","LU0965509101.SGD","LU1066053197.SGD","SG9999002224.SGD","LU1989772923.USD","LU2491050071.SGD","JDOC","LU0130102774.USD","IE00BBT3K403.USD","LU2357627491.SGD","LU1023059063.AUD","TRUH","LU0057025933.USD","SG9999015341.SGD","LU0058720904.USD","LU1699723380.USD","LU1116320737.USD","LU1934455863.HKD","LU2324357040.USD","SG9999015358.SGD","LU1989771016.USD","LU1929549753.HKD","LU0965509283.SGD","LU1571399168.USD","SG9999013999.USD","IYH","LU1291159041.SGD","LU1585245621.USD","LU1037948897.HKD","BK4007","LU2361045086.USD","LU0289961442.SGD","BK4533","LU2112291526.USD","LU0162691827.USD","IE00BLSP4452.SGD","VHT","LU2361044949.HKD","LU2433249047.HKD","LU0130517989.USD","LU1069347547.HKD","LU1032466523.USD","BK4516","SG9999001440.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD","LU0266013472.USD","PPH","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672632267","title":"Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672632267","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672632267?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:12","pubTimestamp":1790867579,"startTime":"0","endTime":"0","summary":"Oxford BioDynamics ( ($GB:OBD) ) has provided an announcement. Oxford BioDynamics Plc, a 3D genomics-focused biotechnology company listed on AIM, p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","DARP","PBE","LNGR","BK4202","BK4585","BMED","IEIH","JDOC","SYNB","XT","GNMX","IBB","BBP","TARK","RSPH","BK4588","AGNG","OXM","GNOM","FHLC","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672500697","title":"Gilead Sciences Announces Dividend of R$ 0.2394442440 Per Unit for Brgildbdr 000","url":"https://stock-news.laohu8.com/highlight/detail?id=2672500697","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672500697?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:56","pubTimestamp":1790863001,"startTime":"0","endTime":"0","summary":"Gilead Sciences announces dividend of R$ 0.2394442440 per unit for BRGILDBDR 000Gilead declared a 3Q 2026 dividend of R$ 0.2394 per unit for ISIN BRGILDBDR000.Shares trade ex-rights from Sept. 11, 202","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL7w2sZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMED","SG9999015945.SGD","BK4588","LU0965509101.SGD","BIB","IE00B7SZLL34.SGD","LU0823416689.USD","BK4550","LU0114720955.EUR","LU0122379950.USD","LU0861579265.USD","TBXU","LU0320765992.SGD","LU2089984988.USD","SG9999015986.USD","LU1430594728.SGD","LU1066051498.USD","BK4139","LU0058720904.USD","BK4585","LU0965509283.SGD","LU1057294990.SGD","LU1066053197.SGD","BMED","BBH","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU0889565916.HKD","IBBQ","LU0965508806.USD","LU0965509010.AUD","BK4568","SG9999015978.USD","IE0002270589.USD","LU1037948897.HKD","LU0109394709.USD","MEDI","IE00B19Z3581.USD","LU2357627491.SGD","IBB","LU1778281490.HKD","LU1037948541.HKD","LU1934455277.USD","IE00B19Z3B42.SGD","LU0859254822.USD","GILD","LU1023059063.AUD","LU1934455863.HKD","LU1571399168.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":7,"totalSize":229,"code":"91000000","status":"200"}]}}